ArticleMedical journal of the Islamic Republic of Iran2022
Evaluation of Progression-Free Survival and Overall Survival of Epidermal Growth Factor Receptor-Positive Metastatic Lung Adenocarcinoma Patients Treated with Erlotinib.
Saeedeh Shahriari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.